AngioDynamics, Inc.
ANGO
$12.34
$0.342.83%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.73% | -3.76% | -12.56% | -13.06% | -12.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.73% | -3.76% | -12.56% | -13.06% | -12.85% |
| Cost of Revenue | -2.46% | -9.67% | -19.91% | -16.54% | -13.75% |
| Gross Profit | 7.58% | 1.94% | -5.25% | -9.68% | -12.00% |
| SG&A Expenses | 4.98% | 0.99% | -1.21% | -0.05% | -2.36% |
| Depreciation & Amortization | -13.27% | -20.92% | -30.75% | -32.69% | -31.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.49% | -6.28% | -12.67% | -10.19% | -8.76% |
| Operating Income | 29.17% | 28.90% | 13.89% | -28.85% | -57.06% |
| Income Before Tax | 86.53% | 82.24% | 78.90% | -2,456.47% | -4,081.92% |
| Income Tax Expenses | -102.77% | 99.46% | 90.41% | -362.38% | 131.79% |
| Earnings from Continuing Operations | 86.79% | 81.56% | 78.48% | -1,491.96% | -3,870.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 86.79% | 81.56% | 78.48% | -1,491.96% | -3,870.26% |
| EBIT | 29.17% | 28.90% | 13.89% | -28.85% | -57.06% |
| EBITDA | 78.24% | 80.52% | 8.19% | -222.55% | -182.39% |
| EPS Basic | 87.03% | 81.78% | 78.70% | -1,480.95% | -4,004.14% |
| Normalized Basic EPS | 43.82% | 45.99% | 37.48% | -15.26% | -29.87% |
| EPS Diluted | 86.97% | 81.71% | 78.60% | -1,476.04% | -4,050.13% |
| Normalized Diluted EPS | 43.82% | 45.93% | 37.41% | -15.41% | -30.05% |
| Average Basic Shares Outstanding | 1.49% | 1.67% | 1.85% | 1.92% | 1.95% |
| Average Diluted Shares Outstanding | 1.49% | 1.59% | 1.77% | 1.84% | 1.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |